Fred D. | 一铭

The newer generation cancer vaccines aren't like the HPV shot (that prevents a virus). These are therapeutic, they treat cancer you already have. And 2026 is the year they stopped being sci-fi. The idea: after surgery, sequence your specific tumor, find the mutations unique to it, and build a custom mRNA vaccine that trains your immune system to hunt any cell carrying them. A wanted poster for your personal cancer. Where we actually are: Melanoma: just like in immunotherapy 15 years ago the furthest along. The press release of positive Phase 3 made the headlines yesterday, the first ever for a personalized cancer vaccine. Earlier data: ~49% lower risk of recurrence. Heading to regulators. Pancreatic cancer: arguably the most stunning. In an early trial, patients whose immune systems responded to the vaccine were far more likely to be alive 6 years later, in a cancer where 5-year survival is barely better than 10 %. Now in a larger trial. Kidney, lung, bladder, brain: all in trials, mostly early phase. The honest caveats: these work best after surgery to stop recurrence, not to melt large tumors. They're personalized, so they might cost $100–300k and take weeks to build per patient. And most are still early-phase. First approvals at best 2027. But the direction is unmistakable. The mRNA platform some parts of the internet spent years calling poison - because they got fooled by bad actors making money on their lies - is turning into the most personalized cancer medicine ever made. These are the main trials currently running: